Atlanta, GA, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Trust Stamp (Nasdaq: IDAI), a global provider of AI-powered technologies, has announced two upcoming events.
Reaffirms New Drug Application (NDA) first quarter 2025 submission guidance Confirms no additional adult clinical trials are necessary prior to NDA submission Commenced pediatric trial in the U.S. and ...